BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12662131)

  • 1. New molecular targets for antianxiety interventions.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytics: past, present, and future agents.
    Nemeroff CB
    J Clin Psychiatry; 2003; 64 Suppl 3():3-6. PubMed ID: 12662127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Better cure for anxiety, sleep disorders, epilepsy?].
    Korpi ER; Wisden W; Lüddens H
    Lakartidningen; 1997 Sep; 94(39):3403-8. PubMed ID: 9379810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAA receptors as targets for novel anxiolytic drugs.
    Rupprecht R; Eser D; Zwanzger P; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of GABA in the pathophysiology and treatment of anxiety disorders.
    Nemeroff CB
    Psychopharmacol Bull; 2003; 37(4):133-46. PubMed ID: 15131523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of GABA in anxiety disorders.
    Lydiard RB
    J Clin Psychiatry; 2003; 64 Suppl 3():21-7. PubMed ID: 12662130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxioselective anxiolytics: can less be more?
    Basile AS; Lippa AS; Skolnick P
    Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.
    Mathew SJ; Price RB; Charney DS
    Am J Med Genet C Semin Med Genet; 2008 May; 148C(2):89-98. PubMed ID: 18412102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H
    Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to developing new anxiolytics and antidepressants.
    Dubovsky SL
    J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanism of action of benzodiazepine and its consequences for therapy].
    Cugurra F
    Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability.
    Costa E; Auta J; Caruncho H; Guidotti A; Impagnatiello F; Pesold C; Thompson DM
    Adv Biochem Psychopharmacol; 1995; 48():75-92. PubMed ID: 7653327
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
    Reynolds DS
    Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety.
    Roy-Byrne PP
    J Clin Psychiatry; 2005; 66 Suppl 2():14-20. PubMed ID: 15762815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives].
    Kostowski W; Płaźnik A
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340
    [No Abstract]   [Full Text] [Related]  

  • 20. Glutamate- and GABA-based CNS therapeutics.
    Foster AC; Kemp JA
    Curr Opin Pharmacol; 2006 Feb; 6(1):7-17. PubMed ID: 16377242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.